These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 18075277)
1. Low CR1 (C3b receptor) level on erythrocytes is associated with poor prognosis in hemodialysis patients. Ohi H; Tamano M; Okada N Nephron Clin Pract; 2008; 108(1):c23-7. PubMed ID: 18075277 [TBL] [Abstract][Full Text] [Related]
2. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum. Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666 [TBL] [Abstract][Full Text] [Related]
3. Recombinant EPO therapy increases erythrocyte expression of complement regulatory proteins. Ohi H; Tamano M; Sudo S; Okada N Am J Kidney Dis; 2003 Jan; 41(1):179-85. PubMed ID: 12500235 [TBL] [Abstract][Full Text] [Related]
4. Low expression of erythrocyte complement receptor type 1 in chronic hepatitis C patients. Kanto T; Hayashi N; Takehara T; Katayama K; Kato M; Akiyama M; Kasahara A; Fusamoto H; Kamada T J Med Virol; 1996 Oct; 50(2):126-34. PubMed ID: 8915878 [TBL] [Abstract][Full Text] [Related]
5. Complement receptor 1 (CD35) on human reticulocytes: normal expression in systemic lupus erythematosus and HIV-infected patients. Lach-Trifilieff E; Marfurt J; Schwarz S; Sadallah S; Schifferli JA J Immunol; 1999 Jun; 162(12):7549-54. PubMed ID: 10358211 [TBL] [Abstract][Full Text] [Related]
6. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation]. Pascual M; Schifferli JA Schweiz Med Wochenschr; 1993 Jan; 123(3):39-43. PubMed ID: 8426946 [TBL] [Abstract][Full Text] [Related]
7. Quantitative polymorphism of complement receptor type 1 (CR1) in patients undergoing haemodialysis. Tamano M; Ohi H; Sudo S; Tomino Y Nephrol Dial Transplant; 2004 Jun; 19(6):1467-73. PubMed ID: 15069174 [TBL] [Abstract][Full Text] [Related]
8. Decreased expression of the C3b/C4b complement receptor (CR1) in AIDS and AIDS-related syndromes correlates with clinical subpopulations of patients with HIV infection. Jouvin MH; Rozenbaum W; Russo R; Kazatchkine MD AIDS; 1987 Jul; 1(2):89-94. PubMed ID: 2966632 [TBL] [Abstract][Full Text] [Related]
9. Abnormal immune adherence and elimination of hepatitis B surface antigen/antibody complexes in patients with AIDS. Madi N; Steiger G; Estreicher J; Schifferli JA J Immunol; 1992 Feb; 148(3):723-8. PubMed ID: 1530955 [TBL] [Abstract][Full Text] [Related]
10. Low erythrocyte complement receptor type 1 (CR1, CD35) expression in preeclamptic gestations. Feinberg BB; Jack RM; Mok SC; Anderson DJ Am J Reprod Immunol; 2005 Dec; 54(6):352-7. PubMed ID: 16305660 [TBL] [Abstract][Full Text] [Related]
11. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism. Craig ML; Bankovich AJ; McElhenny JL; Taylor RP Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886 [TBL] [Abstract][Full Text] [Related]
13. Erythropoietin therapy in humans increases erythrocyte expression of complement receptor type 1 (CD35). Hebert LA; Birmingham DJ; Dillon JJ; Cosio FG; Shen XP J Am Soc Nephrol; 1994 Apr; 4(10):1786-91. PubMed ID: 8068876 [TBL] [Abstract][Full Text] [Related]
14. CR1 levels and gene polymorphisms exhibit differential association with falciparum malaria in regions of varying disease endemicity. Sinha S; Jha GN; Anand P; Qidwai T; Pati SS; Mohanty S; Mishra SK; Tyagi PK; Sharma SK; Venkatesh V; Habib S Hum Immunol; 2009 Apr; 70(4):244-50. PubMed ID: 19480840 [TBL] [Abstract][Full Text] [Related]
15. Association of complement receptor 1 (CR1, CD35, C3b/C4b receptor) density polymorphism with glomerulonephritis in Indian subjects. Katyal M; Tiwari SC; Kumar A; Dinda AK; Arora V; Kumar R; Das N Mol Immunol; 2004 Apr; 40(18):1325-32. PubMed ID: 15072851 [TBL] [Abstract][Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 is a predictor of mortality in stable hemodialysis patients. Hasuike Y; Nonoguchi H; Ito K; Naka M; Kitamura R; Nanami M; Tokuyama M; Kida A; Otaki Y; Kuragano T; Nakanishi T Am J Nephrol; 2009; 30(4):389-98. PubMed ID: 19690405 [TBL] [Abstract][Full Text] [Related]
18. Acquired loss of erythrocyte complement receptor type 1 in patients with diabetic nephropathy undergoing hemodialysis. Wakabayashi M; Ohi H; Tamano M; Onda K; Fujita T; Tomino Y Nephron Exp Nephrol; 2006; 104(3):e89-95. PubMed ID: 16837818 [TBL] [Abstract][Full Text] [Related]
19. Circulating soluble CR1 (CD35). Serum levels in diseases and evidence for its release by human leukocytes. Pascual M; Duchosal MA; Steiger G; Giostra E; Pechère A; Paccaud JP; Danielsson C; Schifferli JA J Immunol; 1993 Aug; 151(3):1702-11. PubMed ID: 8335953 [TBL] [Abstract][Full Text] [Related]
20. Use of complement receptor 1 (CD35) assay in the diagnosis and prognosis of immune complex mediated glomerulopathies. Raju KR; Sivasankar B; Anand V; Luthra K; Tiwari SC; Dinda AK; Das N; Srivastava LM Asian Pac J Allergy Immunol; 2001 Mar; 19(1):23-7. PubMed ID: 11495296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]